Trading in Coloplast shares by board members, executives or associated persons
| Nasdaq Copenhagen 29 August 2018 Report on transactions of executives and related parties in Coloplast shares and related securities |
According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.
The below transaction concerns the exercise of share options (purchase and sale of shares).
| Name | Lars Rasmussen |
| Reason | CEO |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Share options |
| Transaction | Share option exercise (purchase of shares) |
| Trade date | 28 August 2018 |
| Market | NASDAQ Copenhagen |
| Number | 151,183 |
| Transaction value per share in DKK | 385.29 |
| Transaction value in DKK | 58,249,298.07 |
| Name | Lars Rasmussen |
| Reason | CEO |
| Issuer | Coloplast A/S |
| ISIN code | DK0060448595 |
| Description | Share options |
| Transaction | Share option exercise (sale of shares) |
| Trade date | 28 & 29 August 2018 |
| Market | NASDAQ Copenhagen |
| Number | 84,013 & 67,170 |
| Transaction value per share in DKK | 681.44 & 683.04 |
| Transaction value in DKK | 103,129,568.00 |
Calculation of share price:
When calculating the share price in connection with exercise of share options the purchase price is based on the strike price. The strike price is the share price at the grant date. In connection with sales the share price on the time of exercise is used.
Kind regards,
Coloplast A/S
Anne-Sofie Søegaard
Attachment
